The Manufacturers Life Insurance Company bought a new stake in Rocket Lab Corporation (NASDAQ:RKLB – Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 30,919 shares of the rocket manufacturer’s stock, valued at approximately $3,143,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new position in shares of Rocket Lab during the second quarter worth approximately $30,000. Mcguire Capital Advisors Inc. bought a new stake in Rocket Lab during the 4th quarter valued at $27,000. Keating Financial Advisory Services Inc. bought a new stake in Rocket Lab during the 2nd quarter valued at $39,000. Beacon Investment Advisory Services Inc. raised its holdings in Rocket Lab by 364.0% during the second quarter. Beacon Investment Advisory Services Inc. now owns 399 shares of the rocket manufacturer’s stock worth $41,000 after buying an additional 313 shares during the last quarter. Finally, Zions Bancorporation National Association UT acquired a new position in Rocket Lab during the fourth quarter worth $28,000. 71.78% of the stock is owned by institutional investors.
Insider Activity
In other news, CEO Peter Beck sold 1,298,622 shares of the stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $84.92, for a total value of $110,278,980.24. Following the sale, the chief executive officer directly owned 2,715,181 shares of the company’s stock, valued at approximately $230,573,170.52. This represents a 32.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Arjun Kampani sold 88,000 shares of the stock in a transaction on Thursday, June 18th. The stock was sold at an average price of $107.98, for a total value of $9,502,240.00. Following the completion of the sale, the senior vice president owned 264,705 shares in the company, valued at $28,582,845.90. This trade represents a 24.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 3,484,214 shares of company stock valued at $304,166,848. 8.40% of the stock is currently owned by corporate insiders.
Rocket Lab News Roundup
- Positive Sentiment: ARK Invest increased its position. Cathie Wood’s ARK Innovation ETF reportedly purchased approximately 200,303 Rocket Lab shares, worth about $12.8 million, reinforcing bullish sentiment from a high-profile growth investor. Cathie Wood Bets $38M on Block Stock, Adds $13M in Rocket Lab Shares
- Positive Sentiment: Analysts continue to see substantial long-term upside. Bank of America maintained a Buy rating while lowering its target to $110 from $115, and other analysts’ targets remain well above the current trading level. The bullish case depends heavily on successful Neutron development and execution. Rocket Lab Keeps Faltering So Why Does One Big Bank Currently Expect 100% Upside?
- Positive Sentiment: Space-systems expansion supports the growth narrative. Rocket Lab is broadening beyond launches with components including reaction wheels, radios, solar products and optical systems. Its backlog, government relationships and vertically integrated offerings could provide more recurring revenue and reduce reliance on individual launches. Can Rocket Lab’s Spacecraft Component Business Support Growth?
- Neutral Sentiment: Wednesday’s Electron launch is the immediate catalyst. The mission is scheduled after weather-related delays, making a successful flight potentially supportive for sentiment, while another postponement or failure could increase volatility. Rocket Lab Stock Edges Lower Ahead of Wednesday’s Electron Launch
- Negative Sentiment: Technical and execution concerns are weighing on the stock. Shares have fallen sharply from their peak, with a reported “death cross” and an 11% monthly decline. Investors remain focused on Neutron delays and the company’s negative earnings, including a recent EPS miss despite revenue exceeding estimates. Rocket Lab Stock Opinions on Recent Earnings and Stock Decline
- Negative Sentiment: Extensive insider selling adds pressure. Quiver Quantitative data shows no insider purchases and numerous sales over the past six months, including substantial sales by CEO Peter Beck and other executives. This may raise concern about valuation and management confidence, even if some transactions are scheduled or compensation-related.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on RKLB shares. KGI Securities raised shares of Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 target price for the company in a research report on Monday, July 27th. Morgan Stanley reissued an “overweight” rating on shares of Rocket Lab in a report on Wednesday, July 8th. New Street Research assumed coverage on Rocket Lab in a research note on Wednesday, May 13th. They issued a “buy” rating and a $150.00 price objective for the company. Citigroup restated a “market outperform” rating on shares of Rocket Lab in a report on Tuesday, July 28th. Finally, Bank of America cut their target price on Rocket Lab from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday. Three analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Rocket Lab has a consensus rating of “Moderate Buy” and a consensus price target of $110.35.
Read Our Latest Stock Analysis on RKLB
Rocket Lab Stock Performance
Shares of RKLB opened at $62.54 on Wednesday. The firm has a market cap of $37.42 billion, a PE ratio of -231.62 and a beta of 2.61. The stock’s fifty day moving average price is $76.42 and its two-hundred day moving average price is $84.93. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98. Rocket Lab Corporation has a 1 year low of $37.57 and a 1 year high of $151.00.
Rocket Lab (NASDAQ:RKLB – Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%.The firm had revenue of $234.07 million for the quarter, compared to the consensus estimate of $231.62 million. On average, equities research analysts forecast that Rocket Lab Corporation will post -0.2 EPS for the current year.
Rocket Lab Profile
Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.
Further Reading
- Five stocks we like better than Rocket Lab
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB – Free Report).
Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.
